Written in Blood
DLBCL patient population. Also, the trial was designed at a time when the
interval between R-CHOP cycles was uncertain. “Although we did not ob-
serve increased toxicity with a two-week interval schedule (R-CHOP 14), a
three-week delivery (R-CHOP 21)